HSE - PCRS

Application Details

HSE Application ID

HSE100020

HTA Number

25011

HTA Link

https://www.ncpe.ie/rucaparib-rubraca-hta-id-25011/

Drug

rucaparib

Brand

Rubraca®

Applicant

pharmaand GmbH

Indication Applied For

Indicated as monotherapy for the maintenance treatment of adult patients with advanced
(FIGO Stages III and IV) high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based
chemotherapy.

Application Date

20/02/2025

Marketing Authorisation Date

15/11/2023

Application Status